Incidence and clinical outcome of patients with teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and IIA nonseminomatous germ cell tumors Academic Article uri icon

Overview

MeSH Major

  • Germinoma
  • Lymph Node Excision
  • Retroperitoneal Neoplasms
  • Teratoma
  • Testicular Neoplasms

abstract

  • The incidence of teratoma in the retroperitoneum increases with clinical and pathological stage. Teratomatous elements in the orchiectomy specimen predict teratoma in clinical and pathological stage II NSGCT. The absence of teratoma in the primary tumor does not preclude its presence in the retroperitoneum. Primary RPLND avoids the persistence of chemoresistant teratoma in the retroperitoneum, contributes to the high cure rate of patients with low stage NSGCT and decreases the potential for late relapse.

publication date

  • October 2003

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/01.ju.0000087822.71739.9a

PubMed ID

  • 14501715

Additional Document Info

start page

  • 1159

end page

  • 62

volume

  • 170

number

  • 4 I